Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

N/A

7(87.5%)

Phase 3

1(12.5%)

8Total

N/A(7)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT07030673Not ApplicableRecruiting

Early Discontinuation of Antibiotic Therapy in Elderly Patients Hospitalized for a Viral Infection

Role: collaborator

NCT05875038Not ApplicableRecruiting

Superiority of Intelligent Video Surveillance + Telealarm Over Telealarm Alone in Elderly People at Risk of Falling

Role: collaborator

NCT04748796Phase 3Recruiting

Comparison of Landiolol Versus Standard of Care for Prevention of Mortality in Patients Hospitalized for a Septic Shock With Hypercontractility

Role: collaborator

NCT03905239Not ApplicableRecruiting

A Procalcitonin-based Algorithm in Adhesion-related Small Bowel Obstruction

Role: collaborator

NCT06347120Not ApplicableRecruiting

Place of Nasogastric Tube in Uncomplicated Adhesive Small Bowel Obstruction

Role: collaborator

NCT04270136Not ApplicableCompleted

Feasibility of Total Mastectomy in Ambulatory Care

Role: collaborator

NCT02756273Not ApplicableUnknown

Impact of a Bridge Device on the Loop Ileostomy

Role: collaborator

NCT04487171Not ApplicableUnknown

Screening for Postpartum Depression and Associated Risk Factors Among Women Who Deliver in Four Hospital in France During the COVID-19 Epidemic

Role: collaborator

NCT04223297Completed

Blue Protocol Assessment

Role: collaborator

All 9 trials loaded